Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 High prevalence of malaria
3.2.1.2 Support from international organizations
3.2.1.3 Increased awareness and diagnosis
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of production
3.2.2.2 Availability of alternative treatments
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Malaria Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Plasmodium falciparum
5.3 Plasmodium vivax
5.4 Plasmodium ovale
5.5 Plasmodium malariae
5.6 Plasmodium knowlesi
Chapter 6 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Antimalarial injections
6.3 Antimalarial tablets
Chapter 7 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Monotherapy
7.3 Combination therapy
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 AdvaCare Pharma USA LLC
9.2 Calyx Chemicals and Pharmaceuticals Ltd.
9.3 Cipla Limited
9.4 Guilin Pharmaceutical Co., Ltd.
9.5 Ipca Laboratories Ltd.
9.6 KPC Pharmaceuticals, Inc.
9.7 Novartis AG
9.8 Rusan Pharma Ltd.
9.9 Sanofi S.A.
9.10 Shin Poong Pharmaceutical Co., Ltd.
